Cagrilintide + Semaglutide 10MG

Discover Cagrilintide + Semaglutide 10MG, a dual amylin and GLP-1 receptor agonist research blend. This innovative peptide combination is engineered for advanced in vitro studies exploring metabolic regulation, satiety signaling, and glucose homeostasis. Researchers can investigate the combined mechanisms of action in vitro. This blend provides a precise 5mg Cagrilintide + 5mg Semaglutide in a stable, lyophilized form, totaling 10mg. For optimal preservation of its integrity and stability, store the lyophilized blend refrigerated at −20°C. For in vitro research use only. Not for human or veterinary use. Not FDA-approved.

Batch documentation

When a third-party test report for this product is available, it is linked here and in our COA Library with the testing laboratory named. For in vitro laboratory research only. Not for human or veterinary use. This product is not a drug, food or cosmetic and has not been evaluated by the FDA.